We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+6.44%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$350M
AUM Growth
+$9.81M
(+2.9%)
Cap. Flow
-$17.4M
Cap. Flow
% of AUM
-4.98%
Top 10 Holdings %
Top 10 Hldgs %
22.15%
Holding
984
New
159
Increased
201
Reduced
274
Closed
107
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$7.69M |
| 2 |
RSX
VanEck Russia ETF
RSX
|
+$6.34M |
| 3 |
abrdn Physical Gold Shares ETF
SGOL
|
+$5.37M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$4.77M |
| 5 |
iShares MSCI Saudi Arabia ETF
KSA
|
+$4.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.86M |
| 2 |
Stellantis
STLA
|
+$5.95M |
| 3 |
iShares MSCI China ETF
MCHI
|
+$5.61M |
| 4 |
iShares MSCI South Africa ETF
EZA
|
+$3.63M |
| 5 |
VanEck Oil Services ETF
OIH
|
+$3.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.27% |
| 2 | Technology | 10.8% |
| 3 | Consumer Discretionary | 10.51% |
| 4 | Financials | 9.65% |
| 5 | Materials | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DSL
326
DoubleLine Income Solutions Fund
DSL
$1.22B
| $169K | 0.05% |
9,300
| – | – |
|
327
Zymeworks
ZYME
$1.71B
| $167K | 0.05% |
5,288
+1,987
| +60% | +$80.8K |
|
328
Qualcomm
QCOM
$175B
| $164K | 0.05% |
1,239
-400
| -24% | -$57.7K |
|
329
CareDx
CDNA
$1.91B
| $164K | 0.05% |
+2,404
| New | +$187K |
|
330
Alaunos Therapeutics
TCRT
$4.71M
| $163K | 0.05% |
302
+227
| +303% | +$141K |
|
331
iShares Global Healthcare ETF
IXJ
$4.1B
| $162K | 0.05% |
2,107
| – | – |
|
332
Charter Communications
CHTR
$15.4B
| $158K | 0.05% |
256
-1,985
| -89% | -$1.24M |
|
|
GHG
333
GreenTree Hospitality
GHG
$113M
| $158K | 0.05% |
12,000
+5,000
| +71% | +$65.5K |
|
334
Vertex Pharmaceuticals
VRTX
$123B
| $157K | 0.04% |
+731
| New | +$161K |
|
335
Acadia Healthcare
ACHC
$3.06B
| $151K | 0.04% |
2,644
+2,640
| +66,000% | +$143K |
|
|
DQ
336
Daqo New Energy
DQ
$821M
| $151K | 0.04% |
1,998
+302
| +18% | +$27.7K |
|
337
Edwards Lifesciences
EW
$47.6B
| $150K | 0.04% |
1,799
-883
| -33% | -$74.7K |
|
338
Logitech
LOGI
$15.2B
| $150K | 0.04% |
1,425
-98
| -6% | -$10.3K |
|
|
HRC
339
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $148K | 0.04% |
+1,342
| New | +$140K |
|
340
Americold
COLD
$4.15B
| $148K | 0.04% |
3,836
+3,596
| +1,498% | +$129K |
|
341
Avantor
AVTR
$8B
| $147K | 0.04% |
5,084
+1,019
| +25% | +$29.4K |
|
|
GTHX
342
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $147K | 0.04% |
6,110
-40
| -0.7% | -$930 |
|
|
DOCU
343
DocuSign
DOCU
$10.2B
| $145K | 0.04% |
718
-3,334
| -82% | -$773K |
|
344
Vanguard Financials ETF
VFH
$13.5B
| $144K | 0.04% |
+1,710
| New | +$136K |
|
345
Regenxbio
RGNX
$627M
| $142K | 0.04% |
4,158
+200
| +5% | +$8.53K |
|
346
iShares MSCI Germany ETF
EWG
$1.55B
| $142K | 0.04% |
+4,237
| New | +$138K |
|
347
CME Group
CME
$92.4B
| $140K | 0.04% |
684
+326
| +91% | +$64.2K |
|
|
SKX
348
DELISTED
Skechers
SKX
| $139K | 0.04% |
+3,341
| New | +$126K |
|
|
ZNGA
349
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $139K | 0.04% |
13,612
-31,956
| -70% | -$334K |
|
|
HR
350
DELISTED
Healthcare Realty Trust Incorporated
HR
| $138K | 0.04% |
4,564
+4,198
| +1,147% | +$126K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q1 2021 Portfolio in Review
As of Q1 2021, Exane Derivatives held 984 positions worth $350M, up 2.9% from $340M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Exane Derivatives withdrew a net $17.4M in Q1 2021, closing 107 positions and reducing 274 holdings. Its most notable exit was Amazon, an estimated $6.86M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Exane Derivatives opened a new position in Linde worth $11.3M.
- Exane Derivatives's largest Q1 2021 buy was Linde: 29,643 shares worth $11.3M.
- Exane Derivatives added most to VanEck Russia ETF in Q1 2021, an estimated $6.34M increase.
- Exane Derivatives's biggest Q1 2021 reduction was Stellantis, cutting an estimated $5.95M.
- Exane Derivatives fully exited Amazon in Q1 2021, selling an estimated $6.86M.
- Exane Derivatives's ten largest holdings make up 22% of its $350M portfolio in Q1 2021.
- Exane Derivatives opened 159 new positions and closed 107 in Q1 2021.
- Exane Derivatives's portfolio value rose 2.9% quarter-over-quarter to $350M.
Based on Exane Derivatives's 13F filing for Q1 2021, filed 30 Apr 2021.